000 | 01966 a2200577 4500 | ||
---|---|---|---|
005 | 20250515043945.0 | ||
264 | 0 | _c20070314 | |
008 | 200703s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/j.vaccine.2006.09.086 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMinigo, Gabriela | |
245 | 0 | 0 |
_aPoly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy. _h[electronic resource] |
260 |
_bVaccine _cJan 2007 |
||
300 |
_a1316-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
650 | 0 | 4 |
_aMacrophages, Peritoneal _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aOvalbumin _ximmunology |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aPlasmids _xgenetics |
650 | 0 | 4 |
_aPolylysine _xpharmacology |
650 | 0 | 4 | _aPolystyrenes |
650 | 0 | 4 |
_aVaccines, DNA _ximmunology |
700 | 1 | _aScholzen, Anja | |
700 | 1 | _aTang, Choon K | |
700 | 1 | _aHanley, Jennifer C | |
700 | 1 | _aKalkanidis, Martha | |
700 | 1 | _aPietersz, Geoffrey A | |
700 | 1 | _aApostolopoulos, Vasso | |
700 | 1 | _aPlebanski, Magdalena | |
773 | 0 |
_tVaccine _gvol. 25 _gno. 7 _gp. 1316-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2006.09.086 _zAvailable from publisher's website |
999 |
_c16628136 _d16628136 |